Healthcare Industry Today: Anakinra News http://health.einnews.com/news/anakinraConstantly updated news and information about healthcare industry. Cimzia (certolizumab pegol) Reduces Intestinal Lesions and Induces Endoscopic Improvement in Crohn's Patients http://health.einnews.com/news.php?wid=191792107 7 Oct 2008 01:55 GMT ... of Severity (CDEIS)) within ten weeks of treatment in more than 60 percent of the ... was approved by the U.S. Food and Drug Administration on April 22, 2008. The approval ... in clinical studies with concurrent use of anakinra (an interleukin-1 antagonist) and another TNF blocker, ... CIMZIA(R) (certolizumab pegol) Reduces Intestinal Lesions and Induces Endoscopic Improvement in Crohn's Patients http://health.einnews.com/news.php?wid=191717478 6 Oct 2008 20:17 GMT ... of Severity (CDEIS)) within ten weeks of treatment in more than 60 percent of the ... was approved by the U.S. Food and Drug Administration on . The approval was based ... in clinical studies with concurrent use of anakinra (an interleukin-1 antagonist) and another TNF blocker, ... New study proves that pain is not a symptom of arthritis, pain causes arthritis http://health.einnews.com/news.php?wid=191620460 6 Oct 2008 04:48 GMT ... with the results, researchers have identified likely drug targets that could interfere with key inflammatory ... on nerve cells. Existing drugs (e.g. Kineret (anakinra), made by Amgen and indicated for rheumatoid ... a new use for them as osteoarthritis treatment. The implications of this process go further, ...